LICENSE AGREEMENT WITH COLUMBIA UNIVERSITY (Details Narrative) - License Agreement [Member] - Trustees Of Columbia University [Member] $ in Thousands |
9 Months Ended |
|---|---|
|
Sep. 30, 2019
USD ($)
| |
| TFF2 Product [Member] | |
| Percentage of third party royalties payable for reduction in royalties payable | 50.00% |
| Maximum percentage reduction of royalties payable | 50.00% |
| Contingent milestone payment obligation | $ 3,100 |
| Percentage pay of consideration | 5.00% |
| Product (Cocaine Esterase) [Member] | |
| Percentage of third party royalties payable for reduction in royalties payable | 50.00% |
| Maximum percentage reduction of royalties payable | 50.00% |
| Contingent milestone payment obligation | $ 3,000 |
| Percentage pay of consideration | 5.00% |
| X | ||||||||||
- Definition The amount of obligation to make contingent milestone payments to Columbia on a Product-by-Product basis upon the achievement of certain development, approval and sales milestones related to a specific products per license agreements. No definition available.
|
| X | ||||||||||
- Definition The maximum percentage by which royalties payable may be reduced. No definition available.
|
| X | ||||||||||
- Definition The percentage of royalties payable to any third party for intellectual property rights which are necessary for the practice of the rights licensed which may reduce royalties payable on net sales. No definition available.
|
| X | ||||||||||
- Definition The percentage of pay for consideration. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|